[HTML][HTML] Regulatory cells and the effect of cancer immunotherapy

M Iglesias-Escudero, N Arias-González… - Molecular Cancer, 2023 - Springer
Several mechanisms and cell types are involved in the regulation of the immune response.
These include mostly regulatory T cells (Tregs), regulatory macrophages (Mregs), myeloid …

[HTML][HTML] Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

C Groth, X Hu, R Weber, V Fleming, P Altevogt… - British journal of …, 2019 - nature.com
Under steady-state conditions, bone marrow-derived immature myeloid cells (IMC)
differentiate into granulocytes, macrophages and dendritic cells (DCs). This differentiation is …

[HTML][HTML] The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion

P De Cicco, G Ercolano, A Ianaro - Frontiers in immunology, 2020 - frontiersin.org
Suppression of antitumor immune responses is one of the main mechanisms by which tumor
cells escape from destruction by the immune system. Myeloid-derived suppressor cells …

[HTML][HTML] Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives

H Sun, Y Li, P Zhang, H Xing, S Zhao, Y Song… - Biomarker …, 2022 - Springer
Toll-like receptors (TLRs) are a large family of proteins that are expressed in immune cells
and various tumor cells. TLR7/8 are located in the intracellular endosomes, participate in …

Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with advanced-stage ERBB2-positive breast cancer: a phase 1 …

MLN Disis, KA Guthrie, Y Liu, AL Coveler… - JAMA …, 2023 - jamanetwork.com
Importance High levels of ERBB2 (formerly HER2)–specific type 1 T cells in the peripheral
blood are associated with favorable clinical outcomes after trastuzumab therapy; however …

[PDF][PDF] Therapeutic potential of TLR8 agonist GS‐9688 (selgantolimod) in chronic hepatitis B: remodeling of antiviral and regulatory mediators

OE Amin, EJ Colbeck, S Daffis, S Khan… - …, 2021 - Wiley Online Library
Background and Aims GS‐9688 (selgantolimod) is a toll‐like receptor 8 agonist in clinical
development for the treatment of chronic hepatitis B (CHB). Antiviral activity of GS‐9688 has …

[HTML][HTML] Emerging role of RNA sensors in tumor microenvironment and immunotherapy

R Yang, S Yu, T Xu, J Zhang, S Wu - Journal of hematology & oncology, 2022 - Springer
RNA sensors detect foreign and endogenous RNAs to protect the host by initiating innate
and adaptive immune response. In tumor microenvironment (TME), activation of RNA …

[HTML][HTML] Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer

C Salvador-Coloma, A Santaballa, E Sanmartín… - European Journal of …, 2020 - Elsevier
Background Triple-negative breast cancer (TNBC) is characterised by high pathological
complete response to neoadjuvant chemotherapy (NAC). However, refractory and poor NAC …

Toll-like receptors signaling in the tumor microenvironment

KD McCall, M Muccioli, F Benencia - Tumor Microenvironment: Signaling …, 2020 - Springer
The involvement of inflammation in cancer progression is well-established. The immune
system can play both tumor-promoting and-suppressive roles, and efforts to harness the …

[HTML][HTML] Dual roles of myeloid‑derived suppressor cells induced by Toll‑like receptor signaling in cancer

H Zhou, M Jiang, H Yuan, W Ni… - Oncology letters, 2021 - spandidos-publications.com
Myeloid‑derived suppressor cells (MDSCs) are one of the major components of the tumor
microenvironment (TME), and are the main mediators of tumor‑induced …